Results 171 to 180 of about 35,443 (336)
Application of Adverse Outcome Pathways to U.S. EPA’s Endocrine Disruptor Screening Program [PDF]
Patience Browne +3 more
openalex +1 more source
Redox‐Dependent Chaperoning of GBF1 Condensates Regulates Seed Germination in Arabidopsis
In dormant seeds (low ROS), GBF1 forms liquid condensates to repress the germination gene CathB3, and the chaperone GIP1 maintains condensate liquidity and repressive activity. Upon imbibition (high ROS), ROS oxidize GIP1 during germination, impairing its chaperone function.
Yunying Wang, Xiaofeng Fang
wiley +1 more source
Non-chemical, chemical, and biochemical, endocrine disruptors: biphasic health effects and pathophysiological insights. [PDF]
Ulusu NN.
europepmc +1 more source
Liquid Metal Nanotransformers for Drug‐Resistant Pan‐Cancer Therapy in Patient‐Derived Organoids
Pan‐cancer therapies are severely limited in drug‐resistance patients due to genetic mutations and other factors, resulting in poor therapeutic outcomes and constrained clinical benefit. Liquid metal nanotransformers, a new class of shape‐transformable nanomaterials capable of dramatic morphological changes, offer a promising physical strategy to ...
Xiaojie Yuan +19 more
wiley +1 more source
Effects of endocrine disruptors on the neurological system. [PDF]
Karatoprak K, Cander S.
europepmc +1 more source
An activity‐dependent pathway links prefrontal circuit hypoactivity to cognitive impairment. Reduced PVA–mPFC activity upregulates NEPAS, which suppresses PTX3 secretion, leading to impaired angiogenesis, myelin deficits, and memory decline. Rescue is achieved by NEPAS knockdown or chemogenetic circuit activation.
Boya Hu +11 more
wiley +1 more source
Electrochemical synthesis of hydrogen peroxide coupled with UV-C for the oxidation of endocrine disruptor compounds (Abstract) [PDF]
R.J.M. Bisselink, L. Feenstra
openalex

